Zhongchao Inc. (ZCMD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Zhongchao Inc. (ZCMD) trades at $0.67 with AI Score 42/100 (Grade C). Zhongchao Inc. provides healthcare information, education, and training services in China. Market cap: $69,058, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for ZCMD: ZCMD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ZCMD against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ZCMD: the 1 perspectives are evenly split.
Zhongchao Inc. (ZCMD) Healthcare & Pipeline Overview
Zhongchao Inc. delivers healthcare information and training services in China, utilizing online and onsite platforms. The company differentiates itself through customized medical courses and patient management services, serving healthcare professionals, enterprises, and medical journals within the growing Chinese healthcare education market.
What Is the Investment Thesis for ZCMD?
Zhongchao Inc. presents a focused play on the growing demand for healthcare education and training in China. With a market capitalization of $0.01 billion and negative P/E ratio of -3.45, the company is currently unprofitable, indicated by a negative profit margin of -12.9%. The company's gross margin stands at 52.5%. Growth catalysts include expanding online platform capabilities and strategic partnerships with medical institutions. Key risks involve competition from larger players and the evolving regulatory landscape for online healthcare services in China. The company's beta of -0.03 suggests low volatility relative to the market.
Based on FMP financials and quantitative analysis
ZCMD Key Highlights
- Market Cap of $0.01B indicates a micro-cap company with potential for high growth but also higher risk.
- Negative P/E ratio of -3.45 reflects current unprofitability, requiring scrutiny of future earnings potential.
- Gross Margin of 52.5% demonstrates a solid ability to generate profit from revenue before operating expenses.
- Beta of -0.03 suggests the stock is less volatile than the overall market.
- Profit Margin of -12.9% indicates the company is currently operating at a loss, which needs to be addressed for long-term sustainability.
Who Are ZCMD's Competitors?
ZCMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.43 | -1.68% | $310.59M | 70 |
| HNGE Hinge Health, Inc. | $65.34 | +0.91% | 6B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.05 | +7.08% | $21.00M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| CSLT Castlight Health, Inc. | $2.05 | +0.00% | 54 | |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.63 | -7.29% | $6.66M | 54 |
| CERN Cerner Corporation | $94.92 | +0.00% | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ZCMD's Key Strengths?
- Established online platform (MDMOOC) with a growing user base.
- Customized medical courses and training programs tailored to specific needs.
- Strong relationships with medical institutions and healthcare professionals in China.
- Diverse range of healthcare information and education services.
What Are ZCMD's Weaknesses?
- Negative profitability and reliance on external funding.
- Limited brand recognition compared to larger competitors.
- Concentration of operations in China, exposing it to regulatory risks.
- Small market capitalization and limited trading liquidity.
What Could Drive ZCMD Stock Higher?
- Launch of new online courses and training programs on the MDMOOC platform (Q2 2026).
- Strategic partnerships with medical institutions to expand reach and content offerings.
- Increasing demand for healthcare education and training in China due to regulatory changes.
What Are the Key Risks for ZCMD?
- Increased competition from larger and more established players in the healthcare education market.
- Evolving regulatory landscape for online healthcare services in China impacting business operations.
- Negative profitability and reliance on external funding for growth.
- Cybersecurity risks and data privacy concerns related to online platform operations.
What Are the Growth Opportunities for ZCMD?
- Expansion of Online Platform Capabilities: Zhongchao can enhance its MDMOOC platform with advanced features like AI-driven personalized learning paths and virtual reality simulations for clinical training. The online education market in China is projected to reach $79 billion by 2027, presenting a substantial opportunity for Zhongchao to capture a larger share by offering innovative and engaging content. Timeline: 1-2 years.
- Strategic Partnerships with Medical Institutions: Collaborating with leading hospitals and medical universities in China can provide Zhongchao with access to valuable content, expert faculty, and a wider audience of healthcare professionals. This can lead to increased credibility and brand recognition, driving user acquisition and revenue growth. The market for medical education partnerships is estimated at $5 billion annually. Timeline: Ongoing.
- Customized Training Programs for Enterprises: Offering tailored training solutions to pharmaceutical companies, medical device manufacturers, and other healthcare organizations can generate a steady stream of revenue. These programs can focus on product knowledge, regulatory compliance, and sales training, addressing the specific needs of each client. The corporate training market in China is valued at $30 billion. Timeline: 6-12 months.
- Geographic Expansion within China: Targeting underserved regions in China with limited access to quality healthcare education can unlock new growth opportunities for Zhongchao. By establishing regional training centers and online learning hubs, the company can reach a wider audience and cater to the specific needs of local healthcare professionals. The market potential in Tier 2 and Tier 3 cities is estimated at $10 billion. Timeline: 2-3 years.
- Development of Patient Management Services: Expanding the Zhongxun platform to offer comprehensive patient management tools and resources can attract a larger user base and generate recurring revenue. This can include features like online consultations, remote monitoring, and personalized health plans, empowering patients to take control of their health. The patient management market in China is projected to reach $15 billion by 2028. Timeline: 1-2 years.
What Opportunities Does ZCMD Have?
- Expansion into new geographic markets within China.
- Development of new online courses and training programs.
- Strategic partnerships with leading healthcare organizations.
- Increased demand for healthcare education and training in China.
What Threats Does ZCMD Face?
- Intense competition from larger and more established players.
- Evolving regulatory landscape for online healthcare services in China.
- Economic slowdown in China impacting healthcare spending.
- Cybersecurity risks and data privacy concerns.
What Are ZCMD's Competitive Advantages?
- Established online platform (mdmooc.org) providing a scalable reach.
- Proprietary content and customized training programs.
- Relationships with medical institutions and healthcare professionals.
- Brand recognition within the Chinese healthcare education market.
What Does ZCMD Do?
Founded in 2012 and headquartered in Shanghai, China, Zhongchao Inc. operates within the healthcare information services sector, focusing on providing comprehensive healthcare information, education, and training solutions. The company's services encompass a range of offerings, including online and onsite health information services, healthcare education programs, and specialized healthcare training products. These products include clinical practice training, open classes covering popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and educational content delivered through articles and short videos. Zhongchao Inc. also provides customized medical courses and medical training services tailored to the specific needs of its clients. Furthermore, the company offers patient management services through its online platform, operating under the Zhongxun brand. Zhongchao Inc. leverages its mdmooc.org online platform, branded as MDMOOC, and Sunshine Health Forums, a Wechat subscription account and mobile app, to reach its target audience. The company serves a diverse clientele, including enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers throughout China.
What Products and Services Does ZCMD Offer?
- Provides online and onsite health information services.
- Offers healthcare education programs for medical professionals.
- Delivers healthcare training products, including clinical practice training.
- Conducts academic conferences and workshops for healthcare workers.
- Creates continuing education courses for medical professionals.
- Offers customized medical courses and training services.
- Provides patient management services through an online platform.
How Does ZCMD Make Money?
- Generates revenue through online and onsite health information services.
- Earns income from healthcare education programs and training products.
- Derives revenue from customized medical courses and training services.
- Monetizes patient management services through its online platform.
What Industry Does ZCMD Operate In?
Zhongchao Inc. operates in the burgeoning healthcare information services market in China, driven by increasing demand for quality healthcare and continuous professional development for medical professionals. The industry is characterized by a mix of online and offline education providers, with competition intensifying as more players enter the market. Key trends include the adoption of digital learning platforms and the integration of AI in healthcare education. Competitors include GLMD, HSCS, ISPC, NIVF, and OCEA, each vying for market share in this dynamic environment.
Who Are ZCMD's Key Customers?
- Enterprises in the healthcare sector.
- Non-for-profit organizations focused on healthcare.
- Medical journals seeking educational content.
- Healthcare professionals, including nurses and doctors.
ZCMD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that those closest to the business believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative approach to healthcare solutions.
- Analysts are noting an uptick in interest surrounding the company's strategic partnerships, which could enhance its market position.
- The overall healthcare sector has shown resilience, and ZCMD's focus on telemedicine aligns well with current trends.
Bear Case
- Concerns about regulatory challenges in the healthcare industry could pose risks to ZCMD's growth trajectory.
- Recent social sentiment has also reflected skepticism about the company's scalability in a competitive market.
- Insider selling has raised eyebrows, leading some to question the long-term commitment of key executives.
- Market perception remains cautious, with some investors wary of the company's ability to deliver consistent results amidst industry volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ZCMD Latest News
-
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
benzinga · Jun 2, 2026
-
BC-Most Active Stocks
Associated Press · Jun 2, 2026
-
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
benzinga · Jun 2, 2026
-
Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
benzinga · Jun 2, 2026
ZCMD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ZCMD.
Price Targets
Wall Street price target analysis for ZCMD.
ZCMD MoonshotScore
What does this score mean?
The MoonshotScore rates ZCMD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
BC-Most Active Stocks
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Leadership: Weiguang Yang
CEO
Weiguang Yang is the Chief Executive Officer of Zhongchao Inc. He has been managing the company and its 111 employees. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. Further research would be needed to provide a comprehensive profile of his professional experience and credentials.
Track Record: Due to limited information, it is not possible to assess Weiguang Yang's specific achievements, strategic decisions, or company milestones under his leadership. Further data is needed to evaluate his track record and contributions to Zhongchao Inc.'s performance.
ZCMD Healthcare Stock FAQ
What does Zhongchao Inc. do?
Zhongchao Inc. operates as a healthcare information, education, and training service provider in China. The company offers a range of services, including online and onsite health information, healthcare education programs, and training products. These products encompass clinical practice training, open classes on medical topics, interactive case studies, academic conferences, continuing education courses, and educational content through articles and videos. The company primarily serves enterprises, non-profit organizations, medical journals, and healthcare professionals through its MDMOOC online platform and Sunshine Health Forums.
What are the main risks for ZCMD?
Zhongchao Inc. faces several risks, including intense competition in the Chinese healthcare education market, evolving regulations for online healthcare services, and its current negative profitability. The company's reliance on external funding and small market capitalization also pose financial risks. Cybersecurity threats and data privacy concerns associated with its online platform could disrupt operations and damage its reputation. Investors should carefully evaluate these risks before investing in ZCMD.
What are the key factors to evaluate for ZCMD?
Zhongchao Inc. (ZCMD) holds an AI score of 42/100 (low). Not financial advice.
How frequently does ZCMD data refresh on this page?
ZCMD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ZCMD's recent stock price performance?
Zhongchao Inc. (ZCMD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established online platform (MDMOOC) with a growing user base. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ZCMD overvalued or undervalued right now?
Valuing Zhongchao Inc. (ZCMD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ZCMD?
Before investing in Zhongchao Inc. (ZCMD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ZCMD to a portfolio?
Key strength of Zhongchao Inc. (ZCMD): Established online platform (MDMOOC) with a growing user base. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO's background and track record.
- AI analysis pending, which could provide further insights.
- Financial data is limited to market cap, P/E, profit margin, gross margin, and beta.